182 related articles for article (PubMed ID: 6593107)
1. Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels.
Edvinsson L; Ekblad E; Håkanson R; Wahlestedt C
Br J Pharmacol; 1984 Oct; 83(2):519-25. PubMed ID: 6593107
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms underlying pre- and postjunctional effects of neuropeptide Y in sympathetic vascular control.
Pernow J; Saria A; Lundberg JM
Acta Physiol Scand; 1986 Feb; 126(2):239-49. PubMed ID: 3010640
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of neuropeptide Y-induced potentiation of noradrenaline-induced vasoconstriction by PP56 (D-myo-inositol 1,2,6-tris-phosphate).
Adamsson M; Fallgren B; Edvinsson L
Br J Pharmacol; 1992 Jan; 105(1):93-6. PubMed ID: 1596693
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers.
Ekblad E; Edvinsson L; Wahlestedt C; Uddman R; Håkanson R; Sundler F
Regul Pept; 1984 Apr; 8(3):225-35. PubMed ID: 6379758
[TBL] [Abstract][Full Text] [Related]
5. Regional involvement of an endothelium-derived contractile factor in the vasoactive actions of neuropeptide Y in bovine isolated retinal arteries.
Prieto D; Simonsen U; Nyborg NC
Br J Pharmacol; 1995 Nov; 116(6):2729-37. PubMed ID: 8590997
[TBL] [Abstract][Full Text] [Related]
6. Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides.
Wahlestedt C; Yanaihara N; Håkanson R
Regul Pept; 1986 Feb; 13(3-4):307-18. PubMed ID: 3010387
[TBL] [Abstract][Full Text] [Related]
7. Diminished contractile responses to neuropeptide Y of arteries from diabetic rabbits.
Andersson D; Brunkwall J; Bergqvist D; Edvinsson L
J Auton Nerv Syst; 1992 Mar; 37(3):215-22. PubMed ID: 1587998
[TBL] [Abstract][Full Text] [Related]
8. Innervation of human omental arteries and veins and vasomotor response to noradrenaline, neuropeptide Y, substance P and vasoactive intestinal peptide.
Edvinsson L; Håkanson R; Steen S; Sundler F; Uddman R; Wahlestedt C
Regul Pept; 1985 Sep; 12(1):67-79. PubMed ID: 2416012
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y-induced potentiation of noradrenergic vasoconstriction in the human saphenous vein: involvement of endothelium generated thromboxane.
Fabi F; Argiolas L; Ruvolo G; del Basso P
Br J Pharmacol; 1998 May; 124(1):101-10. PubMed ID: 9630349
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action.
Wahlestedt C; Edvinsson L; Ekblad E; Håkanson R
J Pharmacol Exp Ther; 1985 Sep; 234(3):735-41. PubMed ID: 3928874
[TBL] [Abstract][Full Text] [Related]
11. Effects of noradrenaline and neuropeptide Y on rat mesenteric microvessel contraction.
Chen H; Fetscher C; Schäfers RF; Wambach G; Philipp T; Michel MC
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):314-23. PubMed ID: 8692287
[TBL] [Abstract][Full Text] [Related]
12. Effect of neuropeptide Y on the sympathetic contraction of the rabbit central ear artery during cooling.
García-Villalón AL; Padilla J; Fernández N; Monge L; Martínez MA; Gómez B; Diéguez G
Pflugers Arch; 2000 Aug; 440(4):548-55. PubMed ID: 10958338
[TBL] [Abstract][Full Text] [Related]
13. Blockade of neuropeptide Y-induced potentiation of noradrenaline-evoked vasoconstriction by D-myo-inositol-1.2.6-trisphosphate (PP56) in rabbit femoral arteries.
Adamsson M; Edvinsson L
Neuropeptides; 1991 May; 19(1):13-6. PubMed ID: 1891070
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction by an intracellular calcium-dependent mechanism.
Fallgren B; Arlock P; Edvinsson L
J Auton Nerv Syst; 1993; 44(2-3):151-9. PubMed ID: 8227954
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y induces and modulates vasoconstriction in intracranial and peripheral vessels of animals and man.
Hanko JH; Törnebrandt K; Hardebo JE; Kåhrström J; Nobin A; Owman C
J Auton Pharmacol; 1986 Jun; 6(2):117-24. PubMed ID: 3755439
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y in cerebrovascular function: comparison of membrane potential changes and vasomotor responses evoked by NPY and other vasoconstrictors in the guinea pig basilar artery.
Fallgren B; Arlock P; Jansen I; Edvinsson L
Neurosci Lett; 1990 Jun; 114(1):117-22. PubMed ID: 2381572
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y potentiates contraction and inhibits relaxation of rabbit coronary arteries.
Han C; Abel PW
J Cardiovasc Pharmacol; 1987 Jun; 9(6):675-81. PubMed ID: 2442533
[TBL] [Abstract][Full Text] [Related]
18. Endothelium-independent potentiating effects of neuropeptide Y in the rat tail artery.
Small DL; Bolzon BJ; Cheung DW
Eur J Pharmacol; 1992 Jan; 210(2):131-6. PubMed ID: 1318205
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characteristics of the canine cerebrovascular constriction produced by neuropeptide Y.
Uneyama H; Tanaka Y; Iwata S; Ishiguro T; Nakayama K
Biol Pharm Bull; 1995 Apr; 18(4):501-6. PubMed ID: 7655416
[TBL] [Abstract][Full Text] [Related]
20. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
